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Abstract 
The purpose of this study was to look at gender differences in a ST elevation myocardial 
infarction (STEMI), in a population from a large tertiary hospital over one year and three 
months period to see if there were differences in female and male population. Looking at 
the time of onset of symptoms to time in seeking treatment and to see if this had an 
impact on morbidity, treatment modalities, and length of stay in the hospital. The time of 
onset of symptoms to time of treatment is important because of the time-dependent nature 
of reperfusion strategies. This can minimize myocardial damage and have a significant 
impact on mortality and morbidity. Since 1994, the mortality rate has remained higher for 
women than men. This may relate to the delays in seeking treatment for women.  
In this research project the researcher found that there are statistically significant gender 
differences between men and women. This research has shown that women delay longer 
than men in seeking treatment for STEMI, their length of stay is longer, but the 
researcher found no significant differences in morbidity between men and women. This 
could have been because the population was small and the researcher did not show the 
differences in ages.  
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CHAPTER I 
Introduction 
 “Cardiovascular disease (CVD) is the leading cause of mortality for women in 
the United States and globally” (Mehta et al., 2016, p.1.).  The time from onset of acute 
myocardial infarction (AMI) symptoms until hospital arrival is important because of the 
time-dependent nature of reperfusion therapies such as angioplasty and thrombolytic 
therapies. Timely reperfusion therapy for an AMI can minimize myocardial damage with 
positive effects on mortality and morbidity (Lesneski, 2010). Since 1984, the annual 
CVD mortality rate has remained greater for women than men. There have been 
significant sex differences in the pathophysiology, clinical presentation, and clinical 
outcomes of AMIs. This may relate to the delays in seeking treatment in women. Early 
recognition of symptoms and avoidance of delays in seeking treatment are key elements 
in preventing morbidity (Lesneski, 2010).  Guidelines exist for the management of AMI, 
yet despite these, significant inequalities exist in the care of these patients. “The elderly, 
deprived socioeconomic groups, females, and non-Caucasians are the patient populations 
where practices tends to deviate from more frequently from the evidence base” (Rashid, 
Simms, Batin, Kurian, & Gale 2015, p. 895).  
Significance 
CVD remains the leading morbidity and mortality threat affecting millions of 
American women. Reasons for the increased AMI rates in women are multifactorial and 
are related to the prevalence of disease and the influence of age, race and ethnicity 
(Mehta et al., 2016).  There has been a marked reduction in CVD mortality in women as a 
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result of an increase in awareness, more focus on women and heart disease, and the use of 
evidence-based treatments. 
CVD afflicts 6.6 million US women annually. “Regardless of the age, within a 
year of a first AMI, more women than men will die (26% of women and 19% of men); 
within five years of a first AMI, more women than men will die (47% of women and 36% 
of men), have heart failure (HF), or suffer from a stroke “(Mehta et al., 2016, p.2).  
Compared with men, women have longer hospitalizations and higher in-hospital 
mortality, have more bleeding complications, and have up to 30% more readmissions 
within 30 days after the AMI (Mehta et al., 2016).  
There are influences in age and racial/ethnic disparities with women and AMIs. 
Women are often older when they present with their first AMI, at an average age of 71.8 
years compared with 65 years for men. The older age of onset of CVD in women 
compared with men is thought to be due to the protective role of circulating estrogens on 
the vascular endothelium (Mehta et al., 2016). This is resulting from the observation that 
the occurrence of AMI rises substantially in postmenopausal women but it is difficult to 
assess the effect of age from that of menopause. “Racially and ethnically diverse women 
with AMI have distinct experiences in terms of presentation, risk factor burden, evidence-
based care, and long term outcomes (Mehta et al., 2016, p.3).  The prevalence of MI is 
higher in black women than in all other racial and ethnic groups of women (Safford et al., 
2012). Black women also have a higher incidence of sudden cardiac death (SCD) as the 
first manifestation of coronary heart disease (CHD) than white women and their survival 
rate after out-of-hospital-arrest is about one third that of whites (Chan et al., 2009).  
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The symptoms of a myocardial infarction may begin with mild pain or pressure in the 
chest, which could extend through the shoulders, arms, back, teeth, and jaw. Other 
symptoms may include light-headedness, shortness of breath, nausea and vomiting, 
fatigue and fainting. Shin, Martin, & Suls (2009) performed a meta-analysis of symptom 
presentations and found a magnitude of gender difference associated with ACS 
symptoms. The symptoms may vary and may be similar to symptoms of other diseases. 
Therefore, they may wait too long before calling 911 or going to the hospital.  
Even individuals who are aware that there are experiencing an AMI may delay seeking 
care due to a number of reasons including fear, concerns about cost, self-treatment with 
medication, distrust of the health-care system, consulting with family members, and 
embarrassment about calling emergency medical services if the condition turned out not 
to be a myocardial infarction (Fang, 2011). Timely treatment is the key factor to reduce 
mortality from an AMI.  
Present therapeutic strategies fall into three major categories: (a) reperfusion (or 
artery opening) therapies to reestablish blood flow with either thrombolytics or direct 
angioplasty; (b) conjunctive therapy with aspirin and/or heparin to maximize the 
reperfusion and prevent reocclusion; and (c) adjunctive therapies to minimize the 
negative effects of the heart attack with medications such as beta blockers and 
angiotensin converting enzyme inhibitors (Crumlish & Hand, 1999). The shorter the time 
period between symptom onset and reperfusion treatment the better the resulting cardiac 
function due to preservation of heart muscle.  
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A number of studies have shown that women present later to treatment for AMI 
than men. Delays in seeking medical care for symptoms plausibly contribute to poorer 
outcomes for women. Delay in seeking treatment for AMI is often due to lack of 
awareness of risk, passivity, inaccurate system attribution, and barriers to self-care. 
Gender differences in experiencing an MI as a result of coronary artery disease are 
significant, not only with regards to mortality and morbidity, but also in the presentation, 
diagnosis, course, and treatment of coronary artery disease (Higginson, 2008). Additional 
factors associated with increased delay in seeking treatment for AMI include older age, 
female sex, black or Hispanic race, and lower education and socioeconomic levels 
(Mehta et al., 2016).   
Purpose 
The purpose of this thesis was to compare women to men in the effect of time to 
treatment for an acute myocardial infarction and how they compare to length of stay, 
mortality, and treatment modalities. There is a need to educate women on the risks of 
delaying seeking treatment. Clinical practice approaches that focus on the unique aspects 
of cardiovascular care for women are needed to provide necessary resources for the 
prevention, diagnosis, and treatment of cardiovascular treatment in women (Garcia et al., 
2016) 
Theoretical Framework 
The theoretical framework used to guide the thesis is Leventhal Self-Regulatory 
Model (SRM) of illness behavior.  This model proposes that both internal and 
environmental stimuli influence the behavior of an individual when faced with a health 
threat. Internal characteristics include age, gender, ethnicity, and environmental stimuli 
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include the influence of significant others. The framework suggests that cognitive and 
emotional systems make independent contributions to health and illness behavior. It 
outlines three stages of behavior at the time of a health threat (such as having an AMI). 
The first stage relates to an individual’s knowledge, attitudes, and beliefs regarding the 
threat which can impact on levels of anxiety and whether a symptom is judged to be 
serious or not. The second stage refers to how the individual responds by formulating an 
action plan to cope with the symptoms. The final stage describes the evaluation of any 
action taken by an individual and may include input form significant others (Baxter & 
Allmark, 2013).  The concepts used in this thesis are acute myocardial infarction, time to 
treatment, and effects of length of stay, treatment modalities, and morbidity. (See Figure 
1) 
 
CTE Diagram 
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Thesis Question 
In female AMIs, what is the effect of time to treatment as compared to male AMIs 
on length of stay, treatment modalities, and morbidity?  
Definition of Terms 
 Time to treatment is the allotted time from the onset of symptoms in AMI to the 
time of first medical treatment.  
 First Medical Treatment is the place where the first medical treatment began, 
either EMS or hospital emergency room.  
 Length of Stay is the time spent in the hospital. 
 STEMI is an acronym for ST elevation myocardial infarction. 
 PCI is an acronym for percutaneous coronary intervention. 
 Morbidity is a term used to describe a focus on death. 
 Treatment modalities is a therapeutic method or agent used, such as PCI, CABG, 
or Thrombolytic therapy that involves the physical treatment of a disorder.     
Summary 
There is a significant sex differences in presentation, treatments, and outcomes of 
AMIs. Women continue to have higher morbidity, delays in seeking treatment, and worse 
outcomes after AMIs. Clinical practice approaches that focus on women are needed to 
improve these outcomes. There is also a need to educate women on the risks of delaying 
seeking treatment. 
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CHAPTER II 
Literature Review 
A current review of the literature was obtained by using the Cumulative Index to 
Nursing and Allied Health Literature (CINAHL), PubMed, and Medline.  The purpose of 
this review is to explore in female AMIs what are the effects of time to treatment as 
compared to male AMIs on length of stay, treatment modalities, and morbidity. Specific 
attention was directed in the gender differences with AMIs. The areas that were explored 
were gender differences in AMIs, AMI in women, morbidity, and patient delays in 
seeking treatment.  
Patient Delays in Seeking Treatment for AMI 
A large body of research was found regarding patient delays in seeking treatment 
for AMIs. A descriptive comparative study was conducted by Lesneski (2010) to 
examine factors associated with individuals delaying treatment after experiencing 
symptoms of an AMI. In the multiple regression analysis, the following were predictors 
of long treatment delays in arrival to the emergency department after cardiac symptom 
onset: being home, having more ability to control symptoms, and being in a public place. 
Predictors of short treatment delay were thinking that symptoms were heart related, 
calling 911, having a high pain scale, and telling someone else about the symptoms.       
A qualitative study was conducted by Rosenfeld, Lindauer, and Darney (2005) to 
describe the period between the onset of symptoms of myocardial infarction and the 
enactment of the decision to seek care (decision time) and to identify common patterns of 
cognitive, effective, and behavioral responses to the symptoms. In the study 52 women 
were asked in semi structured interviews to describe the symptoms and related thoughts, 
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decisions, and actions from the onset of symptoms of myocardial infarction to arrival at 
the hospital. Narrative analysis was used to examine the stories and to identify patterns of 
decision-making behavior. Six common patterns of behavior during the decision time 
were identified: knowing and going, knowing and letting someone take over, knowing 
and going on the patient’s own terms, knowing and waiting, managing an alternative 
hypothesis and minimizing. The patterns were further grouped as knowing or managing. 
Women in the two groups (knowing and managing) differed primarily in their awareness 
and interpretations of the symptoms and in their patterns of behavior in seeking 
treatment. Women’s delay in seeking treatment for symptoms of myocardial infarction 
can be categorized into distinct patterns. 
A prospective study conducted by Chughtai et al. (2011) was performed to assess 
the impact of pre-hospital time on the patient’s outcome. The study included 60 patients 
from a city community hospital with ST-elevation myocardial infarction. Starting from 
the symptom onset, “total time to treatment” was divided into less than or equal to 120 
minutes (“pre-hospital time” of < or > 30 minutes prospectively). Adverse patient 
outcomes were compared in the two subgroups. Their patients had a mean age of 63 
years. On the scene time (17.8 minutes) was the biggest fraction of “pre-hospital time”. 
Comparing the groups with “total time to treatment” of >120 minutes vs. 120 minutes 
(“pre-hospital time” of >30 minutes vs. <30 minutes), mortalities were 4 vs. 0 and 
transfers to tertiary care facility was 3 vs. 1. Most of the pre-hospital time in STEMI was 
spent on the scene and they suggested “total time to treatment” as a core measure instead 
of “door-to-balloon time”. 
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A descriptive study was conducted by Banks and Dracup (2006) to determine 
factors associated with prolonged delay and the extent to which perceived racism 
influences prehospital delay in African Americans with acute myocardial infarction. 
Sixty-one African Americans with acute myocardial infarction were interviewed within 
one month of hospital admission. Delay times were calculated on the basis of the 
interviews. The results showed a media delay of 4.25 hours and did not differ 
significantly between women and men (4.42 vs. 3.50 hours). Most patients (69%) 
experienced their initial signs and symptoms at home, often witnessed by a family 
member or friend (70%). Delay was longer for insured patients than for uninsured 
patients (4.45 vs. 0.50 hours). Single, widowed, or divorced patients had longer delay 
times than did married patients (5.33 vs. 2.50 hours), and patients with diabetes delayed 
longer than those without diabetes (7.29 vs. 3.50 hours). Perceived racism did not differ 
significantly between patients who delayed seeking treatment and those who did not. 
A retrospective study was conducted by McGinn et al. (2005) to identify trends in 
prehospital delay times and the use of the emergency medical service. The time from 
symptom onset to arrival at hospital and emergency medical service use were abstracted 
from medical records of 18,928 patients hospitalized for AMI and captured in the 
community surveillance component of the ARIC study from 1987 to 2000. A cut point of 
four hours was used to assess clinically relevant delay time recommendations for 
treatment with current therapies. In 2000, the overall proportion of persons with delays 
from symptom onset to hospital arrival of > 4 hours was 49.5%. Blacks and women 
consistently delayed longer than whites and men. Between 1987 and 2000 there were no 
statistically significant changes in the proportion of patients delaying > 4 hours (relative 
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change +0.6% in men, -7.4% in women, -2.3% in whites, -8.9% in blacks, -7.9% in 
persons with diabetes, and -0.8% in persons without diabetes); however there is a 
noticeable narrowing of gaps between sex, race, and diabetes status over the study period. 
The percentage of those who used emergency medical services increased significantly 
over the study period (187 37.1%, 2000 44.5%, p.0001).  
A retrospective study was conducted by Brkovic, Novak, and Puljak (2015) that 
analyzed the most recent trends in myocardial infarction (MI) care, the number of 
patients treated for MI and their outcomes, cardiovascular risks factors, and pain to 
hospital times in MI patients.  For 778 patients treated for acute MI at the Coronary Care 
Unit (CCU) of University Hospital split, Croatia the following data were acquired: 
outcomes during hospitalization (survived, deceased), cardiovascular risk factors, 
(hypertension, diabetes, dyslipidemia, previous MI, smoking), and pain-to-CCU time.  
They found that among 778 patients treated for acute MI, there were 291 (37%) 
women and 487 (63%) men. Forty-five patients (6%) died during hospitalization, mostly 
due to cardiogenic shock. An association was found between early intrahospital mortality 
and the following risk factors: age >70 years, female sex, previous MI, and smoking. 
Median pain to call time was two hours, and median time from the onset of pain to arrival 
into the CCU was four hours. There were 59 (7.6%) patients admitted to the CCU within 
recommended 90 minutes. Diabetic comorbidities were not associated with early death or 
with longer times from pain to emergency call.  
A retrospective analysis study was conducted by Diercks et al0 (2010) to 
determine if the increased emphasis on raising the awareness of the signs and symptoms 
of acute coronary syndrome (ACS) has translated into a decreased time of symptom onset 
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to hospital presentation in women having non-ST segment MI (NSTEMI) who were 
included in two large national ACS registries. The study population comprised patients 
who presented with non-ST segment elevation myocardial infarction in the Can Rapid 
Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early 
Implementation of the American College of Cardiology/American Heart Association 
Guidelines and the National Cardiovascular Data Registry Acute Coronary Treatment and 
Intervention Outcomes Network-Get with the Guidelines registry. Analysis was done 
based on the introduction of the educational intervention: pre-intervention 2002-2003, 
intermediate 2004-2005, and post 2006-2007. Of the 125,262 patients, 50,162 (40.1%) 
were women. The median time from symptom onset to presentation was significantly 
longer in women than men: three hours versus 2.8 hours, a difference that remained 
significant after adjusting for clinical characteristics. There was no measureable reduction 
in the time from symptom onset to presentation over the period of the awareness 
campaign: post versus pre-intervention period. After adjustments for covariates, women 
aged 40 to 60 years had a 3.46% longer time to presentation than men. There was no 
reduction in time from symptom onset to hospital presentation for myocardial infarction 
patients since national awareness campaigns were initiated, and a significant gender gap 
remains.  
A cross-sectional questionnaire study was conducted by Lovlien, Schei, and Hole 
(2008) to explore gender differences in psychosocial aspects in the year prior to first-time 
myocardial infarction, and the association between these aspects and pre-hospital delay. 
In the study, patients diagnosed with first-time myocardial infarction were recruited from 
five Norwegian hospitals over a 13-month period in 2003-2004. Of 738 eligible patients, 
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149 women and 384 men completed a self-administered questionnaire (response rate 
72%). They found that depression, high family stress, high work stress and major life 
events had no statistically significant impact on patient delay or total pre-hospital delay. 
Depression, sleep disturbances, and high family stress were reported among more women 
than men in the year prior to the event. Women and men aged 65 years and younger were 
more likely to report major depression and major life events than those older than 65. 
Low education and low partner education predicted prolonged patient delay in men but 
not in women. Low partner education also predicted prolonged total pre-hospital delay in 
men.  
A qualitative study conducted by Higginson (2008) explored the female 
experience of MI, focusing on some of the thought processes and coping strategies used 
by women when having an MI. Using a grounded theory approach, 25 post MI female 
patients were interviewed about their experiences during an acute MI. Through analyzing 
and coding data, a number of categories emerged that provide insight into the heath 
seeking behaviors of women at the onset of an MI. Emergent categories were: a delay in 
seeking help (main category), an engendered perception of heart disease sub-category), 
not recognizing symptoms (sub-category), maintaining control through self-medication 
(sub-category). Analysis of the data suggests that when experiencing an MI, women 
delay seeking help for a number of reasons, including not recognizing symptoms, 
perceiving heart disease as a “male” problem and preferring to self-medicate. 
A prospective study was conducted by Chen et al. (2015) to assess whether 
gender difference in health insurance help explain gender differences in delay in seeking 
care for the patients in the US, with acute myocardial infarction (AMI). They also 
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assessed gender differences in such prehospital delay for AMI in Spain, a country with 
universal insurance. They used data from 2,951 US and 496 Spanish patients age 18 to 55 
with AMI. US patients were grouped by insurance status: adequately insured, 
underinsured, or uninsured. For each country, they assessed the association between 
gender and prehospital delay (symptom onset to arrival). For the US cohort they modeled 
the relation between insurance groups and delay of >12 hours. US women were less 
likely than men to be uninsured but more likely to be underinsured, and a larger 
proportion of women than men experienced delays of >12 hours (38% vs. 29%). They 
found no association between insurance status and delays of >12 hours in men or women. 
Only 17.3% of Spanish patients had delays of >12 hours, and there were no significant 
gender differences. Women were more likely than men to delay, although it was not 
explained by differences in insurance status. The lack of gender differences in prehospital 
delays in Spain suggests that these differences may vary by health care system and 
culture.  
A retrospective cohort study was conducted by Balsa et al. (2015) to assess the 
impact of gender on the access to reperfusion therapy in patients with acute coronary 
syndrome with ST-segment elevation (STEMI), and to analyze the effect of delay on the 
differences with regards to hospital mortality. A total of 4,816 patients were included 
(22.09% women). Women were older, presented with longer patient delay (90 vs. 75 
minutes), higher risk profile, and received less reperfusion therapy with longer 
reperfusion therapy (307 vs. 240 minutes). Women received less thrombolysis (24% vs. 
29%) and longer door to needle time (85 vs. 70 minutes). They found no differences 
regarding primary percutaneous coronary intervention or door-to-balloon time. Women 
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also had higher hospital mortality, which persisted after controlling the effect of patient 
delay, age, risk, and reperfusion. Compared with men, women with STEMI have worse 
access to reperfusion and higher hospital mortality. The impact of the differences in 
accessibility on mortality gap remains uncertain. 
Gender Differences in AMI 
A prospective registry study was conducted by Pilgrim et al (2015). They 
investigated patients included into the Acute Myocardial Infarction in Switzerland 
(AMIS) registry presenting to one of 11 centers in Switzerland providing primary PCI 
around the clock, and stratified patients according to gender and age. A total of 4,723 
patients presented with AMI between 2005 and 2010; 1,319 (28%) were women and 
2,172 (54%) were > 65 years of age. More than 90% of patients < 65 years of age 
underwent primary PCI without differences between genders. Elderly patients and 
particularly women were at increased risk of being withheld PCI as compared to males 
<65 years of age. An increased risk of delay in door-to-balloon time .90 minutes was 
found in elderly males and females, as well as females <65 years as compared to males < 
65 years of age, with significance differences in circadian patterns during on and off duty 
hours. They observed discrimination of elderly patients and females in the circadian 
provision of primary PCI.  
 Gillis, Arslanian-Engoren, and Struble (2014) conducted a systematic review of 
literature to synthesize the published literature (2000-2012) to examine the initial ED 
presentation of older adults with confirmed acute coronary syndrome (ACS), identify 
knowledge gaps, determine whether gender differences exist in the presentation of ACS, 
and describe recommendations for practice and research. The review suggested that the 
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older adults with ACS report chest pain more commonly when arriving to the emergency 
department. Older adults have higher in-hospital mortality rates than adults aged younger 
than 65 years. However, older adults reporting an absence of chest pain on arrival are 
twice as likely to die compared with older adults with chest pain. With regards to gender 
differences, they noted that men are more likely to present with chest pain whereas 
women are more likely to present with nausea. Women have higher in-hospital mortality 
both with and without chest pain presentation. Delay in time to arrival, as well as delay to 
primary percutaneous intervention, is reported for older adults with and without chest 
pain. 
A retrospective cohort study was conducted by Leifheit-Limson et al. (2015) 
called the VIRGO Study, to compare cardiac risk factor prevalence, risk perceptions, and 
health care provider feedback on heart disease and risk modifications between young 
women and men hospitalized with AMI. They studied 3,501 patients age 18-55 years 
enrolled in the VIRGO (Variation in recovery: Role of Gender on Outcomes of Young 
AMI Patients) study in the US and Spanish hospitals between August 2008 and January 
2012, comparing the prevalence of five cardiac risk factors by sex. Modified Poisson 
regression was used to assess sex differences in self-perceived heart disease risk and self-
reported provider discussions of risk and modification. Nearly all patients (98%) had >1 
risk factor, and 64% had >3. Only 53% of patients considered themselves at risk for heart 
disease, and even fewer reported being told they were at risk (46%) or that their health 
care provider had discussed heart disease and risk modification (49%). Women were less 
likely than men to be told they were at risk or to have a provider discuss risk 
modifications. There was no difference between women and men for self-perceived risk.  
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They found that despite having significant cardiac risk factors, only one-half of young 
AMI patients believed they were at risk for heart disease before their event. Even fewer 
discussed their risks or risk modification with their health care providers; this issue was 
more pronounced among women. 
A meta-analysis was conducted by Shin et al. (2009) to assess the magnitude and 
direction of associations among gender and acute coronary syndrome (ACS) symptom 
presentations, and to evaluate the potential role of the type of symptom measurement 
strategy. They performed a systematic review of articles and dissertations from between 
1966 and 2207. Effect sizes were calculated and meta-analyzed, using random affect 
models. They found gender differences of moderate or larger magnitude were evident,  
and women were more likely than men to report back pain, palpitations, nausea/vomiting, 
and loss of appetite. For most symptoms, the magnitude of effects did not vary across 
different symptom-assessment strategies.  Their conclusions demonstrated substantive 
effects in the magnitude of gender differences in ACS symptoms that were consistent, 
irrespective of measurement approach. 
Mortality 
A retrospective analysis conducted by Zang et al. (2015) assessed gender 
differences in in-hospital mortality according to age in 91,088 patients (35,899 with 
STEMI, 55,189 with NSTEMI) who were 18 to 89 years old and had acute MI as their 
primary diagnosis. Patients with STEMI had significantly higher in-hospital mortality 
than those with NSTEMI. Compared to men women were older, had higher co-morbidity 
scores, and were less likely to undergo revascularization during hospitalization in the 
STEMI and NSTEMI population. In patients with NSTEMI the difference between 
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younger women and younger men was not statistically significant; however, older women 
(>70 years old) had better survival than men. In conclusion, higher risk of in-hospital 
mortality in younger women compared to younger men is more evident in patients with 
STEMI.  
A prospective study was conducted by Bufe et al. (2010) to investigate if women 
treated predominately with percutaneous intervention (PCI) in myocardial infarction after 
seven years had the same prognosis as men. Between 1999 and 2001, 500 consecutive 
patients at the Wuppertal Heart Centre were treated with PCI after acute STEMI. A long-
term follow-up (up to seven years) was achieved in 97% of the patients. In comparison to 
men, women were seven years older (65 vs. 58) and had significantly more diabetes 
mellitus. The time between onset of symptoms and interventions tended to be longer in 
women than men. There was no difference in 30 day mortality (8.9% vs. 6.6%), cardiac 
late mortality (3.6% vs. 3.2%), and long term cardiac overall mortality up to seven years 
(12.1% vs. 9.6%). Stepwise regression analysis did not identify female gender as an 
independent predictor of late mortality. The quality of life was comparable. In 
conclusion, there is no gender related difference in the long-term outcome if patients 
were systemically treated with PCI in STEMI. PCI in STEMI has a long lasting positive 
effect in women, and should be the treatment of choice for women with acute myocardial 
infarction. 
 A population based retrospective cohort study was conducted by Izadnegahdar et 
al. (2014) to provide a sex and age–specific, population-based analysis of ten year trends 
in AMI, hospitalization rates, with a particular focus on younger adults, and to determine 
whether in recent years there is any evidence of excess mortality risk in younger women 
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compared with younger men, after AMI hospitalization. They assessed trends and sex 
differences in AMI hospitalization and 30-day mortality rates using negative binominal 
and logistic regression. From 2000 to 2010 there were 70, 628 AMI hospitalizations in 
adults >20 years, in British Columbia, Canada, with 17% of cohort being <55 years of 
age. Overall, age-standardization AMI rates declined similarly in men and women. 
However, these trends differed accordingly to age with increased rates observed only in 
younger women. The 30-day mortality rates declined similarly for women and men. Yet, 
younger women continued to have excess mortality risk, compared with younger men, 
even in the most recent period. In conclusion while the overall AMI hospitalization and  
30-day mortality rates significantly declined in women and men, hospitalization rates in 
women <55 years increased and their excess risk of 30-day mortality persisted.  
In a retrospective cohort study Khera et al. (2015) sought to determine the 
temporal trends and sex differences in revascularization and in-hospital outcomes of 
younger patients with STEMI.  They used the 2004 to 2011 Nationwide Inpatient Sample 
databases to identify all patients age 18 to 59 years hospitalized with STEMI. Temporal 
trends and sex differences in revascularization strategies, in-hospital mortality, and 
length-of-stay were analyzed. From 2004 to 2011, of 1,363,492 younger adults (age <60 
years) with acute myocardial infarction, 632,930 (46.4%) had STEMI. Younger women 
with acute myocardial infarction were less likely than men to present with STEMI. 
Younger women with STEMI were less likely to receive reperfusion therapy as compared 
to younger men. From 2004 to 2011, use of percutaneous intervention for STEMI 
increased both in women and men. In-hospital mortality was significantly higher in 
younger women compared to men (4.5% vs., 3.0%). There was an increasing trend in 
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risk-adjusted in-hospital mortality in both younger men and women during the study 
period. Length of stay decreased in both younger men and women. Younger women are 
less likely to receive revascularization for STEMI and have higher in-hospital mortality 
as compared to younger men. Use of percutaneous coronary intervention for STEMI and 
in-hospital mortality has increased, whereas length of stay has decreased in both sexes 
over the past several years. 
Treatment 
A prospective study was conducted by Ferraz-Torres, Brlzunegui-Otano, Marin-
Ferandez, Matinez-Garcia, & Ibanez-Beroiz (2015) to analyze the differences in the 
treatment and evolution of acute coronary syndromes according to the gender of the 
patient and to determine the likely causes of those differences. This study was conducted 
on 56 patients treated in the hospital emergency service of the Hospital Complex of 
Navarra, Spain from 1 January 2012 to April 2013 with acute coronary syndromes. A 
bivariate and logistic analysis was made by adjusting the age and severity of process to 
know the differences by gender. A total of 71.8% (n=428) were men, and the remaining 
28.2 5 (n=168) were women. The mean age of men was 66 years, and the mean age for 
women was 72. They found that antiplatelet drugs, blockers, ACE inhibitors, fibrinolysis 
and primary angioplasty were less frequently administered to women compared to men. 
They observed an additional delay in the demands for health care in women with acute 
coronary syndromes compared with men. They found there is an association between 
treatment differences in gender. The delay in the request for health care in women was 
observed to be the largest correlating factor, in addition to voluntary discharge in women 
affected by acute coronary syndrome.  
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A prospective analysis was conducted by Moriel et al. (2008) to assess gender 
aspects of contemporary treatment and adherence to ACC/AHA Class I Treatment 
Guidelines in patients with acute coronary syndrome (ACS). They studied 2,024 
consecutive patients (519 women, 26%); 1026 (51%) with ST-elevation (STEMI) and 
998 (49%) patients with NSTEMI, during a nationwide ACS-survey, conducted during 
two months in 2004. Women were older than men, and had worse cardiovascular risk 
profiles. At discharge, fewer women received ACE-inhibitors/ARBs. Among NSTEMI 
patients, fewer women received IIb/IIIa-inhibitors and clopidogrel at discharge. No 
gender differences were noted in utilization of aspirin, beta-blockers or statins. Age-
adjusted and covariate adjusted mortality rates were comparable in women and men with 
STEMI (at seven-days 4.3% vs. 4.1%, and at one-year 13.8% vs. 9.8%; in women and 
men with NSTEMI (at seven-days 1.3% vs. 2.1% and one-year 12% vs. 11.3%). In 2004, 
adherence to ACC/AHA Class I Treatment Guidelines in ASC patients was satisfactory. 
Relative underutilization of acute perfusion was noted among STEMI patients, without 
gender differences after age-adjustment. At discharge, fewer women received ACE-
inhibitors/ARBs. Among NSTEMI patients, less women than men received IIb/IIIa-
inhibitors, and clopidogrel at discharge.      
Theoretical Framework 
A conventional systematic review of published evidence was conducted by Baxter 
and Allmark (2013) to investigate the theoretical frameworks underpinning studies 
exploring the issue of why people having a heart attack delay seeking professional 
medical help. The study used standard review methods to identify papers meeting this 
inclusion criterion, and carried out a synthesis of data related to theoretical underpinning. 
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Thirty-six papers from the 53 in the original systematic review referred to a particular 
theoretical perspective, or contained data, which related to theoretical assumptions. The 
most frequently mentioned theory was the self-regulatory model of illness behavior. 
Papers reported the potential significance of aspects of this model including different 
coping mechanisms, strategies of denial, and varying models of treatment seeking. 
Studies also drew attention to the potential role of belief systems, applied elements of 
attachment theory, and referred to models of maintaining integrity, ways of knowing, and 
the influence of gender. 
An analysis of a focus group discussion conducted by Nymark, Mattiason, 
Henriksson, and Kiessling (2009), describes the care-seeking process for interpretation of 
an initial symptom to the decision to seek medical care in patients with an acute 
myocardial infarction. A focus group discussion with patients who had had a recent acute 
myocardial infarction was analyzed and the self-regulatory model of illness behavior 
inspired the transcribed text. Patients with acute myocardial infarction describe problems 
to identify the exact time of onset of often-vague symptoms. Their experiences of 
symptoms did not meet their expectations. These patients exhibit self-regulatory illness 
behavior that seems to cause a considerable delay in care seeking. They found indications 
of a pertinent shift in appraisal and coping-strategy when a patient changes from self-
regulative illness behavior to seeking care-the turning point. This shift seems to be 
affected by several partly contradictory influences and it takes a considerable time for a 
person to reach this stage. All aspects of the patients’ self-regulative illness behavior have 
to be considered if we want patients to seek medical care more rapidly. 
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A qualitative study conducted by Dullaghan et al. (2013) explored and compared 
patients’ illness perception and motivation for behavioral changes following myocardial 
infarction treated by different methods. Semi-structured interviews (n=15) based on the 
common sense model of self-regulation, were conducted with three groups of MI patients 
within four weeks of diagnosis; (a) primary percutaneous coronary intervention (PPCI)  
(n=5); (b) thrombolysis (n=5); (c) non-ST elevation MI (NSTEMI) (n=5). Framework 
analysis was used to identify and compare themes between groups. The patients 
presenting with a ST-elevation MI (STEMI) receiving either PPCI or thrombolysis had 
similar perceptions of their illness as a serious, life-threatening event and were 
determined to make lifestyle changes. In contract, patients with a NSTEMI experienced 
uncertainty about symptoms and diagnosis, causing misconceptions about the severity of 
their condition and less determination for lifestyle changes. Patients with NSTEMI in this 
study expressed very different perceptions of their illness compared to those with 
STEMI.  Patients’ clinical presentation and treatment experience during an AMI can 
impact their illness perception, motivation for behavioral change and uptake of cardiac 
rehabilitation. 
Summary 
           The review of the literature showed that there are a large amount of studies that 
show there are gender differences in the effects of delaying treatment in acute myocardial 
infarction. The literature showed that women have higher mortality than men in regards 
to acute myocardial infarction, especially in younger women. The literature also showed 
that there are treatment differences in women compared to men. Studies showed that 
there continues to be a gender gap in regards to acute myocardial infarction.  
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CHAPTER III 
Methodology 
Female acute myocardial infarctions (AMIs) are the leading cause of death for 
females.  The time to onset of symptoms to treatment is important in the effects of 
mortality, treatment, and length of stay. The purpose of this thesis is to compare women 
to men in the effects of time to treatment.  
Study Design 
This is a retrospective quantitative study that looks at data collected from a data 
collection tool for acute myocardial infarctions (AMI) that was put in a database in a 
large tertiary care center that treats AMIs. The differences in male and female data will 
be observed over a one year and three months’ time frame.  
Setting and Sample 
The setting for the study is a large tertiary care center that treats AMIs. The 
sample includes STEMI patients from a 1,000 bed hospital and rural counties in the 
surrounding area that sends patients to this hospital. The hospital accepts STEMI patients 
regardless of bed status from several surrounding counties. Participant information was 
obtained from a data base registry of STEMI patients from that hospital and those 
received from the outlying region. The criteria used for collecting data, was any patient 
that presented to that hospital having an AMI or STEMI.  
Design for Data Collection 
The research design consists of a team of data collectors that are trained to extract 
data from the patient’s medical record that are placed into a nationwide registry. There 
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are no patient identifiers except medical record. No informed consent was obtained since 
this is a retrospective study. 
Measurement Methods 
The data collection tool used is the NCDR ACTION Registry-GWTG tool that 
collects detailed in-hospital clinical, process-of-care and outcomes data for patients 
admitted with acute myocardial infarction (AMI) in the USA. Approximately 350 fields 
encompassing patient demographics, medical history and risk factors, hospital 
presentation, initial cardiac status, medications and associated doses, reperfusion 
strategies, procedures, laboratory values, and outcomes (Peterson et al, 2010). Main 
outcomes measures include American College of Cardiology/ American Heart 
association myocardial infarction performance indicators, as well as in-hospital patient 
outcomes. 
Data Collection Procedures 
The data elements that are central to the ACTION Registry-GWTG include the 
ACC/AHA performance measures and Class I recommendations of the ACC/AHA 
clinical practice guidelines. Other data elements include patient demographics, presenting 
features, pre, acute, and discharge medications, and timing of care delivery, laboratory 
tests, procedures used, and in hospital patient outcomes. Data are limited to only the in 
hospital admission (Peterson et al, 2010).  Trained data collectors that specifically collect 
data for the hospital collect the data. The data is collected from patients with a primary 
diagnosis of ST-segment elevation myocardial infarction (STEMI) or non-ST-segment 
elevation myocardial infarction (NSTEMI) is eligible for enrollment into the database. 
These patients must have: (1) ischemic symptoms at rest, lasting 10 minutes or more, 
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occurring within 24 hours before admission or up to 72 hours for STEMI; and (2) EKG 
changes associated with STEMI (new left-bundle branch block or persistent ST-segment 
elevation >1mm in two or more contiguous ECG leads; or (3) positive cardiac markers 
associated with STEMI within 24 hours after initial presentation. Therefore, only 
confirmed AMI are entered into the database.  
Protection of Human Subjects 
  Prior to conducting the study, the researcher obtained permission from the 
University’s Internal Review Board (IRB) as well as from the hospital that obtained the 
data. All subjects are anonymous at the level of analysis. There is no risk to the subjects. 
Consent was not necessary since no personal health information was obtained.  
Data Analysis 
Data was gathered from an excel spreadsheet that was provided to the researcher 
from the data collectors and placed in a statistical analysis program such as SPSS. The 
researcher looked at key outcomes of length of stay, and morbidity, secondary outcomes 
of PCI (percutaneous intervention), CABG (coronary artery bypass grafting), and 
Thrombolytic therapy. The predictor variables were delay in seeking care, sex, and 
diabetes.  
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CHAPTER IV 
Results 
Delay in seeking treatment in AMIs is important to the outcomes of length of 
stay, morbidity, and treatments. The purpose of this thesis was to compare women to men 
in the effects of delay in seeking treatment.  
Sample Characteristics 
The final sample size was 630 AMIs that presented to the hospital for treatment 
over one year and three months. The descriptive statistics were obtained for delay in 
seeking treatment in minutes, length of stay in days, age, gender, race, diabetes, 
morbidity, PCI, CABG, and thrombolytic therapy. Of the population (n=630), 436 
(69.2%) were male, and 168 (26.7%) were female, 584 (92.7%) were of white race, 20 
(3.2%) were non-white, and 157 (24.9%) were diabetic. In the population, 583 (92.5%) 
were alive at discharge, and 21 (3.3%) were deceased. The mean length of stay was 3.98 
days. The mean time for symptom onset to treatment (delay in seeking treatment) was 
244.06 minutes. Of the population regarding treatment modalities, 518 (82.2%) received 
a percutaneous coronary intervention (PCI), 39 (6.2%) received a CABG (coronary artery 
bypass grafting), and 31 (4.9%) received thrombolytic therapy.  
Major Findings 
The purpose of this thesis was to compare women to men in the effect of time to 
treatment for an acute myocardial infarction and how they compare to length of stay, 
mortality, and treatment modalities. In regards to delay in seeking treatment the 
difference between the mean for female (316.90 minutes) and the mean for male (215.56 
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minutes) is statistically significant at the 0.01 level. (t = 3.56, p < 0.000 two-tailed). (See 
Table 1 and Figures 2 and 3)   
 
Table 1.  
Delay in Seeking Treatment in Minutes 
 
Sex N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Delay in Seeking Treatment in 
Minutes 
Male 414 215.56 265.510 13.049 
 
Female 162 316.90 393.457 30.913 
 
 
 
 
 
 
Figure 2. Delay in Seeking Treatment in Minutes Histogram for Females 
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Figure 3. Delay in Seeking Treatment in Minutes Histogram for Males  
 
    
In testing if delay in seeking treatment effects length of stay, we do not reject the 
hypothesis that delay in seeking treatment effects length of stay (t = 0.143, p < .001, two-
tailed). When comparing male to female in length of stay there was no significant 
difference. (t = -0.988, p < .323, two-tailed). (See Table 2 and Figures 4 and 5)  
 
Table 2 
Length of Stay 
 Sex N Mean Std. Deviation Std. Error Mean 
Length of Stay Male 436 3.90 3.070 .147 
 
Female 168 4.18 3.136 .242 
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Figure 4. Length of Stay Histogram for Males 
 
 
Figure 5. Length of Stay Histogram for Females 
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When comparing delay in seeking treatment and mortality there is a statistically 
significant difference in those that lived and those deceased (t = -2.4, p < .014, two-
tailed). Looking at the difference in male and female and morbidity, a Chi-Square Test 
was performed with a p value < .117, so there was no statistically significant difference in 
male and female morbidity. (See Table 3) 
 
Table 3 
Delay in Seeking Treatment and Mortality  
 Mortality N Mean Std. 
Deviation 
Std. Error 
Mean 
Delay in Seeking Treatment in 
Minutes 
Alive 557 238.21 303.937 12.878 
 
Deceased 19 415.74 427.733 98.129 
 
 
 
In regards to treatment modalities, a linear regression was performed to examine 
the association of PCI, CABG, and thrombolytic therapy and the following set of 
predictor variables of delay in seeking treatment, sex, and diabetes. The research found 
that with PCI a R-Square of .024, and a statistically significant p value of 0.029. The odds 
ratio for delay in seeking treatment was 1.697. The research found with thrombolytic 
therapy there was a R Square of 0.034. Delay in seeking treatment had a statistically 
significant p value of 0.037 and an odds ratio of .443. 
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Summary 
When comparing female to male AMIs there were some significant differences 
and there were some differences that were not significant. The research found that 
women significantly delay longer than men in seeking treatment with AMIs. This 
research found that it did effect some outcomes and morbidity. 
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CHAPTER V 
Discussion 
According to the research purpose, to compare delay in seeking treatment in 
women and men acute myocardial infarctions (AMI) and the effect it has on length of 
stay, morbidity, and treatment modalities, the statistical data revealed that there were 
some significant differences in women delaying longer than men, delaying in seeking 
treatment does effect length of stay, and delay in seeking treatment does effect the 
morbidity. There was no significant data to suggest that women have a higher morbidity 
than women in this population.  
Implications of Findings 
The literature showed that delay in seeking treatment can affect the outcomes in 
AMIs. The results found in this research showed that it effected outcomes except for the 
morbidity in women. The literature showed in younger women morbidity was higher. 
This research did not specify age differences. There are gender differences in AMIs that 
need to be addressed with education in the communities to increase awareness in women. 
Delay in seeking treatment has detrimental outcomes to those having an AMI.  
Applications to Theoretical Framework 
The theoretical framework for this study was Leventhal Self-Regulatory Model 
(SRM) of illness behavior.  This model proposes that both internal and environmental 
stimuli influence the behavior of an individual when faced with a health threat. Internal 
characteristics include age, gender, ethnicity and environmental stimuli include the 
influence of significant others. The researcher found that the study showed that the 
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theoretical framework supported the theory. The delay in seeking treatment for an AMI is 
supported by this theory. 
Limitations 
The limitations of this study include the time frame could have been longer to get 
a larger population. This study only included the AMIs that made it to the hospital and 
were treated, those AMIs that died at home and in the field were not included in the data 
registry. This study only included the population in one large hospital in one state.  
Implications for Nursing 
The findings of this study showed that there are gender differences in AMIs. 
Teaching in the community and to health care providers the importance of including 
these differences, and to be aware of differences in presentation, is important in 
recognizing an AMI. Clinical practice approaches that focus on the unique aspects of 
cardiovascular care for women are needed to provide necessary resources for the 
prevention, diagnosis, and treatment of cardiovascular disease in women (Garcia et al., 
2016). 
Recommendations 
The researcher felt that the study could have been improved by including more 
than one hospital, and have the study include a larger time frame. In the future, 
recommendations would be made to have a larger sample and to include age differences 
and include those AMIs that die before they get to treatment.  
Conclusion 
Delay in seeking treatment is an important element to look at with AMIs. This 
study and the literature review showed that delay in seeking treatment has a bad outcome 
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for those having an AMI. This study and the literature review showed that delay in 
seeking treatment effects morbidity, length of stay in the hospital, and treatment 
modalities. 
Women also have significantly higher delays in seeking treatment. The literature 
showed that younger women had higher morbidity than others. This study did not look at 
age differences in the population. This study did not show a significant gender difference 
in morbidity. With future studies, the researcher recommends a larger population, a 
longer timeframe, include those that do not make it to treatment, more hospitals than just 
one tertiary center, and look at age differences in morbidity. 
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